Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: Understanding clinical trial results

  1. Ocaña, A.
  2. Amir, E.
  3. Pandiella, A.
Revue:
Oncotarget

ISSN: 1949-2553

Année de publication: 2018

Volumen: 9

Número: 61

Pages: 31915-31919

Type: Révision

DOI: 10.18632/ONCOTARGET.25739 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus